Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications.

MLA

Prieto, Belén, et al. “Plasma Procalcitonin Measured by Time-Resolved Amplified Cryptate Emission (TRACE) in Liver Transplant Patients. A Prognosis Marker of Early Infectious and Non-Infectious Postoperative Complications.” Clinical Chemistry and Laboratory Medicine, vol. 46, no. 5, 2008, pp. 660–66. EBSCOhost, https://doi.org/10.1515/cclm.2008.123.

APA

Prieto, B., Llorente, E., González-Pinto, I., & Alvarez, F. V. (2008). Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications. Clinical Chemistry and Laboratory Medicine, 46(5), 660–666. https://doi.org/10.1515/cclm.2008.123

Chicago

Prieto, Belén, Elena Llorente, Ignacio González-Pinto, and Francisco V Alvarez. 2008. “Plasma Procalcitonin Measured by Time-Resolved Amplified Cryptate Emission (TRACE) in Liver Transplant Patients. A Prognosis Marker of Early Infectious and Non-Infectious Postoperative Complications.” Clinical Chemistry and Laboratory Medicine 46 (5): 660–66. doi:10.1515/cclm.2008.123.